New Research to Examine Effects of Vitamin E on Obesity

Leslie Shen, Ph.D., C.C.R.P

Of the 13 essential vitamins, vitamin E is known to benefit vision, reproduction and a person’s blood, brain and skin. Researchers at Texas Tech University Health Sciences Center (TTUHSC) now are studying vitamin E to examine the effects of the vitamin on obesity with obese adults.
Vitamin E has antioxidant properties that protect cells against molecules produced when your body breaks down food. Leslie Shen, Ph.D., C.C.R.P., a TTUHSC professor in the Department of Pathology, said these molecules may play a role in other diseases such as obesity.

“The presence of chronic low-grade inflammation in obese people plays an important role in the development of obesity- associated insulin resistance, diabetes and cardiovascular disease,” Shen said. “Among these risk factors, obesity is now recognized as a worldwide epidemic disease. Obesity-induced chronic low-grade inflammation is initiated by excess nutrients in metabolic cells.”

Shen said aging and the decline of estrogen are factors that contribute to weight gain in postmenopausal women, and approaches, such as anti-inflammatory potential in dietary antioxidants to reduce inflammation may likely combat obesity. TTUHSC researchers are conducting a 24-week research study examining the effects of tocotrienols, a type of vitamin E, on obesity-associated outcome measures in obese men and women.

Participants are needed for this study, “Effect of Tocotrienol (vitamin E isomers) on Obesity.” Shen said other studies have indicated tocotrienols supplements may be good for mitigating negative impacts of obesity in obese adults.

“However, no study has ever been done on the role of tocotrienols in obesity in adult men and women,” Shen said. “Our long-term goal is to develop a new strategy featuring a dietary supplement such as tocotrienols for mitigating negative impacts of obesity in adult men and women.”

Participants should be adult men and women. Participation is free of charge. The study is funded by a grant from School of Medicine, TTUHSC, the Laura W. Bush Institute for Women’s Health and American River Nutrition, L.L.C.  

For more information about this research study, contact the Clinical Research Institute at (806) 743-4471 or via email.

Leslie Shen, Ph.D., C.C.R.P.,

Related Stories

Research

TTUHSC Researchers Collaborate in Study of Cancer Drug’s Possible Positive Effects on Alzheimer’s Disease

A drug typically used to treat some forms of cancer may also help delay the progression of Alzheimer’s disease. Boris Decourt, Ph.D., director of the TTUHSC Laboratory on Neurodegeneration and Translational Research, is part of the Phase II trial.

Research

TTUHSC Professor Reflects on Decades of Research Benefitting Thousands of Families

After nearly 50 years with the university, Samuel Prien, Ph.D., has been packing up his office in preparation for retirement in August. Although he’s moving on, his impact at TTUHSC will remain.

Research

Student Research Shows Positive Outcomes from Summer Research Program

Medical student involvement in research is growing, encouraging medical schools to develop programs that support student research plus faculty time for research and mentorship. The Medical Student Summer Research Program (MSSRP) at TTUHSC provides these opportunities, and new research shows positive outcomes.

Recent Stories

Education

TTUHSC Recognized for Commitment to Improving Experiences and Advancing Outcomes for First-Generation College Students

FirstGen Forward announced TTUHSC is a new member of the FirstGen Forward Network Class of 2026. FirstGen Forward selected TTUHSC because the university demonstrated a commitment to improving experiences and advancing success for first-generation college students.

Research

TTUHSC Researchers Collaborate in Study of Cancer Drug’s Possible Positive Effects on Alzheimer’s Disease

A drug typically used to treat some forms of cancer may also help delay the progression of Alzheimer’s disease. Boris Decourt, Ph.D., director of the TTUHSC Laboratory on Neurodegeneration and Translational Research, is part of the Phase II trial.

Education

TTU System Board of Regents Approves Appointment of Grover E. Murray Professor

The Texas Tech University System Board of Regents today (Aug. 13) approved the appointment of Rodney Young, M.D., from the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine, as a Grover E. Murray Professor.